Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
The current price of 6869.MX is M$307.32 MXN — it has increased by +5.13% in the past 24 hours. Watch Sysmex stock price performance more closely on the chart.
What is Sysmex stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sysmex stocks are traded under the ticker 6869.MX.
What is Sysmex revenue for the last year?▼
Sysmex revenue for the last year amounts to 128.23B MXN.
What is Sysmex net income for the last year?▼
6869.MX net income for the last year is 13.91B MXN.
Does Sysmex pay dividends?▼
Yes, 6869.MX dividends are paid semi-annual. The last dividend per share was 1.97 MXN. As of today, Dividend Yield (FWD)% is 0%.
When did Sysmex complete a stock split?▼
The last stock split for Sysmex was on April 02, 2024 with a ratio of 1.5:1.